Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Vanda Pharmaceuticals (VNDA) Depreciation Expense (2017 - 2025)

Vanda Pharmaceuticals' Depreciation Expense history spans 9 years, with the latest figure at $301000.0 for Q4 2025.

  • For Q4 2025, Depreciation Expense rose 14.89% year-over-year to $301000.0; the TTM value through Dec 2025 reached $1.1 million, up 22.22%, while the annual FY2025 figure was $1.1 million, 22.22% up from the prior year.
  • Depreciation Expense for Q4 2025 was $301000.0 at Vanda Pharmaceuticals, roughly flat from $301000.0 in the prior quarter.
  • Across five years, Depreciation Expense topped out at $374000.0 in Q4 2021 and bottomed at $200000.0 in Q3 2023.
  • The 5-year median for Depreciation Expense is $279000.0 (2022), against an average of $276000.0.
  • The largest annual shift saw Depreciation Expense plummeted 33.11% in 2023 before it skyrocketed 39.35% in 2025.
  • A 5-year view of Depreciation Expense shows it stood at $374000.0 in 2021, then dropped by 28.61% to $267000.0 in 2022, then dropped by 23.22% to $205000.0 in 2023, then rose by 27.8% to $262000.0 in 2024, then increased by 14.89% to $301000.0 in 2025.
  • Per Business Quant, the three most recent readings for VNDA's Depreciation Expense are $301000.0 (Q4 2025), $301000.0 (Q3 2025), and $267000.0 (Q2 2025).